This page is part of the FHIR Specification (v3.2.0: R4 Ballot 1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3
Patient Care Work Group | Maturity Level: 1 | Draft | Use Context: Any |
This is a value set defined by the FHIR project.
Summary
Defining URL: | http://hl7.org/fhir/ValueSet/adverse-event-causality-assess |
Name: | AdverseEventCausalityAssessment |
Definition: | TODO |
Committee: | Patient Care Work Group |
OID: | 2.16.840.1.113883.4.642.3.840 (for OID based terminology systems) |
Source Resource | XML / JSON |
This value set is used in the following places:
This value set includes codes from the following code systems:
http://hl7.org/fhir/adverse-event-causality-assess
This expansion generated 20 Dec 2017
This value set contains 6 concepts
Expansion based on http://hl7.org/fhir/adverse-event-causality-assess version 3.2.0
All codes from system http://hl7.org/fhir/adverse-event-causality-assess
Code | Display | Definition |
Certain | Certain | i) Event or laboratory test abnormality, with plausible time relationship to drug intake ii) Cannot be explained by disease or other drugs iii) Response to withdrawal plausible (pharmacologically, pathologically) iv) Event definitive pharmacologically or phenomenologically (i.e. an objective and specific medical disorder or a recognized pharmacological phenomenon) v) Re-challenge satisfactory, if necessary |
Probably-Likely | Probably/Likely | i) Event or laboratory test abnormality, with reasonable time relationship to drug intake ii) Unlikely to be attributed to disease or other drugs iii) Response to withdrawal clinically reasonable iv) Re-challenge not required |
Possible | Possible | i) Event or laboratory test abnormality, with reasonable time relationship to drug intake ii) Could also be explained by disease or other drugs iii) Information on drug withdrawal may be lacking or unclear |
Unlikely | Unlikely | i) Event or laboratory test abnormality, with a time to drug intake that makes a relationship improbable (but not impossible) ii) Disease or other drugs provide plausible explanations |
Conditional-Classified | Conditional/Classified | i) Event or laboratory test abnormality ii) More data for proper assessment needed, or iii) Additional data under examination |
Unassessable-Unclassifiable | Unassessable/Unclassifiable | i) Report suggesting an adverse reaction ii) Cannot be judged because information is insufficient or contradictory iii) Data cannot be supplemented or verified |
See the full registry of value sets defined as part of FHIR.
Explanation of the columns that may appear on this page:
Lvl | A few code lists that FHIR defines are hierarchical - each code is assigned a level. For value sets, levels are mostly used to organise codes for user convenience, but may follow code system hierarchy - see Code System for further information |
Source | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
Code | The code (used as the code in the resource instance). If the code is in italics, this indicates that the code is not selectable ('Abstract') |
Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
Definition | An explanation of the meaning of the concept |
Comments | Additional notes about how to use the code |